These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 15565568)

  • 1. Randomized trial of leuprorelin and flutamide in male patients with hepatocellular carcinoma treated with tamoxifen.
    Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire
    Hepatology; 2004 Dec; 40(6):1361-9. PubMed ID: 15565568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tamoxifen combined with octreotide or regular chemotherapeutic agents in treatment of primary liver cancer: a randomized controlled trial.
    Pan DY; Qiao JG; Chen JW; Huo YC; Zhou YK; Shi HA
    Hepatobiliary Pancreat Dis Int; 2003 May; 2(2):211-5. PubMed ID: 14599971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose tamoxifen in the treatment of inoperable hepatocellular carcinoma: A multicenter randomized controlled trial.
    Chow PK; Tai BC; Tan CK; Machin D; Win KM; Johnson PJ; Soo KC;
    Hepatology; 2002 Nov; 36(5):1221-6. PubMed ID: 12395333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized controlled trial of tamoxifen in advanced hepatocellular carcinoma.
    Barbare JC; Bouché O; Bonnetain F; Raoul JL; Rougier P; Abergel A; Boige V; Denis B; Blanchi A; Pariente A; Milan C; Bedenne L
    J Clin Oncol; 2005 Jul; 23(19):4338-46. PubMed ID: 15994145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of advanced hepatocellular carcinoma with tamoxifen and the correlation with expression of hormone receptors: a prospective randomized study.
    Liu CL; Fan ST; Ng IO; Lo CM; Poon RT; Wong J
    Am J Gastroenterol; 2000 Jan; 95(1):218-22. PubMed ID: 10638587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of hepatocellular carcinoma with combined suppression and inhibition of sex hormones: a randomized, controlled trial.
    Manesis EK; Giannoulis G; Zoumboulis P; Vafiadou I; Hadziyannis SJ
    Hepatology; 1995 Jun; 21(6):1535-42. PubMed ID: 7768497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II study of flutamide in the treatment of hepatocellular carcinoma.
    Chao Y; Chan WK; Huang YS; Teng HC; Wang SS; Lui WY; Whang-Peng J; Lee SD
    Cancer; 1996 Feb; 77(4):635-9. PubMed ID: 8616754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Primary treatment for stage D2 prostate cancer: a randomized study of combined androgen blockade alone versus combined with UFT].
    Sumiyoshi Y; Hashine K; Kuwahara M; Aki M; Yamamoto A; Akazawa S; Takenaka A
    Gan To Kagaku Ryoho; 1999 Jul; 26(8):1153-8. PubMed ID: 10431581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gynecomastia and breast pain induced by adjuvant therapy with bicalutamide after radical prostatectomy in patients with prostate cancer: the role of tamoxifen and radiotherapy.
    Di Lorenzo G; Perdonà S; De Placido S; D'Armiento M; Gallo A; Damiano R; Pingitore D; Gallo L; De Sio M; Autorino R
    J Urol; 2005 Dec; 174(6):2197-203. PubMed ID: 16280763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized placebo-controlled study of long-acting octreotide for the treatment of advanced hepatocellular carcinoma.
    Yuen MF; Poon RT; Lai CL; Fan ST; Lo CM; Wong KW; Wong WM; Wong BC
    Hepatology; 2002 Sep; 36(3):687-91. PubMed ID: 12198662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment with all-trans retinoic acid plus tamoxifen and vitamin E in advanced hepatocellular carcinoma.
    Clerici C; Castellani D; Russo G; Fiorucci S; Sabatino G; Giuliano V; Gentili G; Morelli O; Raffo P; Baldoni M; Morelli A; Toma S
    Anticancer Res; 2004; 24(2C):1255-60. PubMed ID: 15154656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of pravastatin on survival in patients with advanced hepatocellular carcinoma. A randomized controlled trial.
    Kawata S; Yamasaki E; Nagase T; Inui Y; Ito N; Matsuda Y; Inada M; Tamura S; Noda S; Imai Y; Matsuzawa Y
    Br J Cancer; 2001 Apr; 84(7):886-91. PubMed ID: 11286466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tamoxifen is not effective in good prognosis patients with hepatocellular carcinoma.
    Gallo C; De Maio E; Di Maio M; Signoriello G; Daniele B; Pignata S; Annunziata A; Perrone F;
    BMC Cancer; 2006 Jul; 6():196. PubMed ID: 16863588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uracil-tegafur as an adjuvant for hepatocellular carcinoma: a randomized trial.
    Hasegawa K; Takayama T; Ijichi M; Matsuyama Y; Imamura H; Sano K; Sugawara Y; Kokudo N; Makuuchi M
    Hepatology; 2006 Oct; 44(4):891-5. PubMed ID: 17006925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of low dose 5-fluorouracil and cisplatin intra-arterial infusion chemotherapy in advanced hepatocellular carcinoma with decompensated cirrhosis].
    Lim TY; Cheong JY; Cho SW; Sim SJ; Kim JS; Choi SJ; Choi JW; Kwon HC; Lee KM; Kim JK; Won JH; Yoo BM; Lee KJ; Hahm KB; Kim JH
    Korean J Hepatol; 2006 Mar; 12(1):65-73. PubMed ID: 16565607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized controlled trial of tamoxifen versus placebo in inoperable hepatocellular carcinoma.
    Elba S; Giannuzzi V; Misciagna G; Manghisi OG
    Ital J Gastroenterol; 1994 Mar; 26(2):66-8. PubMed ID: 8032079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant hepatic chemotherapy after resection of solitary hepatocellular carcinoma associated with hepatitis B virus cirrhosis.
    Wen J; Shen WL; Yang SH
    Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):224-7. PubMed ID: 16698580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the combined treatment with thalidomide, megestrol and interleukine-2 in cirrhotic patients with advanced hepatocellular carcinoma. A pilot study.
    Cappa FM; Cantarini MC; Magini G; Zambruni A; Bendini C; Santi V; Bernardi M; Trevisani F
    Dig Liver Dis; 2005 Apr; 37(4):254-9. PubMed ID: 15788209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Palliative chemotherapy for patients with recurrent hepatocellular carcinoma after liver transplantation.
    Lee JO; Kim DY; Lim JH; Seo MD; Yi HG; Oh DY; Im SA; Kim TY; Bang YJ
    J Gastroenterol Hepatol; 2009 May; 24(5):800-5. PubMed ID: 19175825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of sorafenib in patients with advanced hepatocellular carcinoma in consideration of concomitant stage of liver cirrhosis.
    Wörns MA; Weinmann A; Pfingst K; Schulte-Sasse C; Messow CM; Schulze-Bergkamen H; Teufel A; Schuchmann M; Kanzler S; Düber C; Otto G; Galle PR
    J Clin Gastroenterol; 2009; 43(5):489-95. PubMed ID: 19247201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.